Results for tag: "Afatinib"

Afatinib is a type of lung cancer drug used to treat non-small cell lung cancer (NSCLC). It is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. It is used to treat NSCLC that has spread to other parts of the body and is caused by a mutation in the epidermal growth factor receptor (EGFR) gene. Afatinib is usually taken orally once a day and is usually used in combination with other treatments such as chemotherapy or radiation therapy. Afatinib is a relatively new drug and is still being studied in clinical trials. It has been approved by the US Food and Drug Administration (FDA) for the treatment of NSCLC and is available in many countries around the world. Some companies in the Afatinib market include Boehringer Ingelheim, AstraZeneca, Pfizer, and Eli Lilly. Show Less Read more